These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7690450

  • 41. M1 and M3 muscarinic receptor subtypes in rat forebrain.
    Pavia J, Marquez E, Laukkonen S, Martos F, Gómez A, Sánchez de la Cuesta F.
    Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
    [Abstract] [Full Text] [Related]

  • 42. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
    [Abstract] [Full Text] [Related]

  • 43. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE.
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [Abstract] [Full Text] [Related]

  • 44. Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.
    Lysíková M, Fuksová K, Elbert T, Jakubík J, Tucek S.
    Br J Pharmacol; 1999 Jul; 127(5):1240-6. PubMed ID: 10455271
    [Abstract] [Full Text] [Related]

  • 45. Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors.
    Maggio R, Vogel Z, Wess J.
    Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):3103-7. PubMed ID: 8385357
    [Abstract] [Full Text] [Related]

  • 46. Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers.
    Wess J, Bonner TI, Dörje F, Brann MR.
    Mol Pharmacol; 1990 Oct 01; 38(4):517-23. PubMed ID: 2172767
    [Abstract] [Full Text] [Related]

  • 47. Interactions between gallamine and muscarinic receptors: allosterism and subpopulation specificity are separate phenomena.
    Ellis J, Seidenberg M.
    Eur J Pharmacol; 1987 Nov 24; 144(1):39-44. PubMed ID: 3436360
    [Abstract] [Full Text] [Related]

  • 48. Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors.
    Pittel Z, Wess J.
    Mol Pharmacol; 1994 Jan 24; 45(1):61-4. PubMed ID: 8302281
    [Abstract] [Full Text] [Related]

  • 49. Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.
    Waelbroeck M, Camus J, Tastenoy M, Christophe J.
    Br J Pharmacol; 1992 Jan 24; 105(1):97-102. PubMed ID: 1596694
    [Abstract] [Full Text] [Related]

  • 50. Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide.
    Huang XP, Prilla S, Mohr K, Ellis J.
    Mol Pharmacol; 2005 Sep 24; 68(3):769-78. PubMed ID: 15937215
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
    Keller M, Tränkle C, She X, Pegoli A, Bernhardt G, Buschauer A, Read RW.
    Bioorg Med Chem; 2015 Jul 15; 23(14):3970-90. PubMed ID: 25650309
    [Abstract] [Full Text] [Related]

  • 54. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor.
    Ehlert FJ, Oliff HS, Griffin MT.
    J Pharmacol Exp Ther; 1996 Feb 15; 276(2):405-10. PubMed ID: 8632303
    [Abstract] [Full Text] [Related]

  • 55. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
    Lanzafame A, Christopoulos A, Mitchelson F.
    J Pharmacol Exp Ther; 1997 Jul 15; 282(1):278-85. PubMed ID: 9223565
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.
    Lazareno S, Popham A, Birdsall NJ.
    Mol Pharmacol; 2000 Jul 15; 58(1):194-207. PubMed ID: 10860942
    [Abstract] [Full Text] [Related]

  • 60. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
    Endou M, Hattori Y, Gando S, Kanno M.
    J Cardiovasc Pharmacol; 1992 May 15; 19(5):674-81. PubMed ID: 1381764
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.